Quarterly Results

ADS DIAGNOSTIC LTD.

NSE : NABSE : 523031ISIN CODE : Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 11.3411.34
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
71.3
77.24
32.58
54.1
Total Expenditure
63.28
61.41
31
43.06
PBIDT (Excl OI)
8.02
15.83
1.58
11.04
Other Income
NA
NA
NA
NA
Operating Profit
8.02
15.83
1.58
11.04
Interest
1.6
1.85
0.7
1.37
Exceptional Items
NA
NA
NA
-8.9
PBDT
6.42
13.98
0.87
0.77
Depreciation
0.41
0.41
0.42
0.41
Profit Before Tax
6.01
13.57
0.45
0.36
Tax
1.78
3.02
0.05
-0.33
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
4.23
10.55
0.40
0.69
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
4.23
10.55
0.40
0.69
Equity Capital
21.93
21.93
21.93
21.93
Face Value (IN RS)
10
10
10
10
Reserves
21.26
21.26
21.26
Calculated EPS
1.92
4.81
0.18
0.31
Calculated EPS (Annualised)
7.71
19.24
0.74
1.25
No of Public Share Holdings
1197390
1197390
1197390
1197390
% of Public Share Holdings
54.61
54.61
54.61
54.61
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
11.24
20.49
4.84
20.40
PBIDTM%
11.24
20.49
4.84
20.40
PBDTM%
9.00
18.09
2.70
1.42
PBTM%
8.42
17.56
1.41
0.66
PATM%
5.93
13.65
1.25
1.27
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.